Buggypower is a biotechnology company specialized in the design, construction and operation of microalgae production units.
Rosário Bronze, Associate Professor at the School of Pharmacy of the University of Lisbon (FFUL), is head of the Food Functionality and Bioactives Lab at iBET and ITQB NOVA and of the Toxicological and Bromatology Lab at FFUL.
The EC has officially approved the “TRANSVAC2” project. This project has as coordinating institution the European Vaccine Initiative (EWIV) and a maximum grant amount of 10 M€ for 60 months.
Genibet is a CDMO (Contract Development and Manufacturing Organization) created in 2006, with headquarters in Oeiras and that is dedicated to the manufacture of biopharmaceutical products.
NUTRACEUTICALS Europe Summit & Expo, took place in Madrid (Spain) on the 22nd and 23rd February and gathered the sector of the functional and novel ingredients.
The project was led by GenIbet (www.genibet.com) in partnership with iBET and the Novartis Vaccines Institute for Global Health. Read here the interview with GenIbet's CEO, Raquel Fortunato.
Bernardo Abecasis, PhD student at the Animal Cell Technology Unit (iBET/ITQB NOVA), was awarded with the Best Poster Snapshot Presentation at the Scale-Up and Manufacturing of Cell-based Therapies V08.02.2017
The conference took place at San Diego, California, USA (15-19 January).
Improved tumor cell models are paramount to overcome current shortcomings of pre-clinical research and drug discovery02.01.2017
A perspective view from the team of the Advanced Cell Models Laboratory | Animal Cell Technology Unit of iBET and partners from AbbVie.
Yesterday iBET received the visit of Frank Stangenberg-Haverkamp, Chairman of the Executive Board of Merck KG04.11.2016
During his visit to Portugal, Frank Stangenberg-Haverkamp took the opportunity to visit two research institutes that showcase the high scientific expertise that Portugal has offer: iBET and Fundação Champalimaud.
The first ESACT Frontiers Retreat took place October 20th – 22nd 2016 in Lyon, France